Back to Trends

eli lilly mounjaro cardiovascular approval

Trending on Friday, August 28, 2026

Peak Traffic

2,000+

News Articles

3

Country

US

Search Domains Google Search Google Trends

Related News

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

US FDA approves Lilly's Mounjaro to reduce cardiovascular risk

Reuters
Read more
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes

Eli Lilly and Company
Read more
Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease

Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease

Bloomberg.com
Read more
Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients

Fierce Pharma
Read more
Weight-loss drug may lower risk of heart attacks and infections

Weight-loss drug may lower risk of heart attacks and infections

Harvard Health
Read more